Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Rule 2.10 Announcement

1 Mar 2010 07:00

RNS Number : 8092H
Consort Medical PLC
28 February 2010
 



Consort Medical PLC

 

Rule 2.10 Announcement

 

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers (the "Code"), Consort Medical plc ("Consort") confirms that it has 28,943,922 ordinary shares of 10 pence each in issue. The International Securities Identification Number for the ordinary shares is GB0000946276.

 

Evercore Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Consort and for no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than Consort for providing the protections afforded to clients of Evercore Partners Limited or for providing advice in relation to the matters set out in this announcement.

 

Dealing Disclosure Requirements

 

Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, 'interested' (directly or indirectly) in 1 per cent. or more of any class of 'relevant securities' of Consort or of Advanced Medical Solutions Group plc ("AMS"), all 'dealings' in any 'relevant securities' of Consort or of AMS (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by not later than 3.30 p.m. (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which any offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Consort or AMS, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Consort or of AMS by Consort or AMS or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

 

A disclosure table, giving details of companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk.

 

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RTTUWSKRRNAUUAR
Date   Source Headline
28th Jan 20201:47 pmRNSForm 8.3 - Consort Medical plc
28th Jan 202012:41 pmBUSForm 8.3 - CONSORT MEDICAL PLC
28th Jan 202011:43 amRNSForm 8.3 - Consort Medical Plc
28th Jan 20209:58 amRNSForm 8.3 - Consort Medical plc
27th Jan 20203:30 pmRNSForm 8.3 - CSRT LN
27th Jan 20203:25 pmBUSForm 8.3 - Consort Medical plc
27th Jan 20203:21 pmRNSForm 8.5 (EPT/RI) - Amendment
27th Jan 20202:11 pmRNSForm 8.3 - Consort Medical Plc
27th Jan 20201:40 pmRNSForm 8.3 - Consort Medical Plc
27th Jan 202012:46 pmBUSFORM 8.3 - CONSORT MEDICAL PLC
27th Jan 202010:07 amRNSHolding(s) in Company
27th Jan 202010:07 amRNSHolding(s) in Company
27th Jan 202010:06 amRNSHolding(s) in Company
27th Jan 20209:30 amRNSForm 8.5 (EPT/RI)
24th Jan 20204:26 pmRNSForm 8.5 (EPT/RI) - Amendment
24th Jan 20204:25 pmRNSForm 8.5 (EPT/RI) - Amendment
24th Jan 20204:23 pmRNSForm 8.3 - Consort Medical PLC
24th Jan 20204:16 pmRNSReplacement Form 8 (DD) - Consort Medical PLC
24th Jan 20204:15 pmRNSCorrection Statement
24th Jan 20201:27 pmRNSForm 8.5 (EPT/RI) - Consort Medical PLC - Restated
24th Jan 20201:17 pmRNSForm 8.3 - Consort Medical plc
24th Jan 202012:14 pmBUSForm 8.3 - Consort Medical Plc
24th Jan 202010:39 amRNSForm 8.5 (EPT/RI)
24th Jan 202010:35 amRNSForm 8.3 - Consort Medical plc
24th Jan 20209:46 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
24th Jan 20207:00 amRNSOffer Extension and Acceptance Level Update
23rd Jan 20204:58 pmRNSForm 8.3 - Consort Medical plc
23rd Jan 20204:11 pmRNSForm 8.3 - Consort Medical PLC
23rd Jan 20203:11 pmRNSForm 8.3 -CONSORT MEDICAL PLC
23rd Jan 20203:00 pmBUSForm 8.3 - Consort Medical Plc
23rd Jan 20201:58 pmRNSForm 8.3 - Consort Medical Plc
23rd Jan 20201:53 pmRNSForm 8.5 (EPT/RI) - Consort Medical PLC - Restated
23rd Jan 20201:43 pmEQSForm 8.3 - The Vanguard Group, Inc.: Consort Medical plc
23rd Jan 20201:30 pmBUSForm 8.3 - CONSORT MEDICAL PLC
23rd Jan 20201:22 pmRNSForm 8.5 (EPT/RI) - Consort Medical PLC - Restated
23rd Jan 20201:22 pmBUSForm 8.3 - CONSORT MEDICAL PLC
23rd Jan 202012:49 pmRNSHolding(s) in Company
23rd Jan 202012:00 pmRNSForm 8.5 (EPT/RI) - Consort Medical PLC
23rd Jan 202011:58 amRNSForm 8.3 - Consort Medical PLC
23rd Jan 202011:54 amRNSForm 8.3 - Consort Medical Plc
23rd Jan 202011:41 amRNSForm 8 (DD) - Consort Medical PLC
23rd Jan 202011:20 amRNSForm 8.5 (EPT/RI)
23rd Jan 202010:44 amRNSForm 8.3 - Consort Medical Plc
23rd Jan 20209:51 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
23rd Jan 20207:46 amRNSForm 8.3 - Consort Medical Plc
23rd Jan 20207:00 amRNSForm 8.3 - Consort Medical PLC
22nd Jan 20203:27 pmBUSForm 8.3 - CONSORT MEDICAL PLC
22nd Jan 20203:18 pmRNSForm 8.3 - CONSORT Medical PLC
22nd Jan 20202:38 pmRNSForm 8.3 - Consort Medical Plc
22nd Jan 20202:27 pmRNSForm 8.3 - Consort Medical plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.